Skip to main content

Published locations for Nivolumab plus ipilimumab boosts response rate in refractory esophagogastric cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Nivolumab plus ipilimumab boosts response rate in refractory esophagogastric cancer

User login

  • Reset your password
  • /content/nivolumab-plus-ipilimumab-boosts-response-rate-refractory-esophagogastric-cancer
  • /oncologypractice/article/173199/immuno-oncology/nivolumab-plus-ipilimumab-boosts-response-rate
  • /hematology-oncology/article/173199/immuno-oncology/nivolumab-plus-ipilimumab-boosts-response-rate